trending Market Intelligence /marketintelligence/en/news-insights/trending/hx-g-ecrxt_rcp_dwtb75g2 content esgSubNav
In This List

Immune Therapeutics appoints board member

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Immune Therapeutics appoints board member

Immune Therapeutics Inc. appointed Jack Brewer as a board member.

Brewer is the CEO and founder of the Brewer Group Cos. He manages Brewer's private portfolio, which focuses on impact investing.

Immune Therapeutics said that Brewer has assisted in the company's expansion into international markets, such as Malawi and Haiti, and has recently started work to help the company expand registration into India.

Orlando, Fla.-based Immune Therapeutics develops immunotherapies for autoimmune and inflammatory diseases, cancer, HIV/AIDS and animal diseases.